Journal article
Vitamin D insufficiency is associated with an increased risk of early clinical failure in follicular lymphoma
Blood cancer journal (New York), Vol.7(8), pp.e595-e595
08/25/2017
DOI: 10.1038/bcj.2017.70
PMCID: PMC5596381
PMID: 28841207
Abstract
We evaluated whether vitamin D insufficiency (VDI; 25(OH)D < 20 ng/ml) was associated with adverse outcomes among follicular lymphoma (FL) patients using an observational prospective cohort study of 642 FL patients enrolled from 2002-2012. The median age at diagnosis was 60 years. At a median follow-up of 59 months, 297 patients (46%) had an event (progression, treatment failure), 78 had died and 42 (6.5%) had a lymphoma-related death. VDI was associated with inferior event-free survival (EFS) at 12 months (EFS12, odds ratio (OR) = 2.05; 95% confidence interval (CI) 1.18-3.54), overall survival (OS, hazards ratio (HR) = 2.35; 95% CI 1.37-4.02), and lymphoma-specific survival (LSS, HR = 2.97; 95% CI 1.52-5.80) for the full cohort. Among patients treated with immunochemotherapy (IC), VDI was associated with inferior EFS12 (OR = 3.00; 95% CI 1.26-7.13), OS (HR = 2.86; 95% CI 1.39-5.85), and LSS (HR = 2.96; 95% CI 1.29-6.79). For observed patients, VDI was associated with inferior OS (HR = 2.85; 95% CI 1.20-6.76). For other therapies, VDI was associated with inferior OS (HR = 3.06; 95% CI 1.01-9.24). Our work is the first to reveal an association of VDI with early clinical failure, and to demonstrate an association of VDI with adverse outcomes among patients who are observed or treated with therapies other than IC. Our findings suggest a potentially modifiable prognostic factor to address in patients with FL.
Details
- Title: Subtitle
- Vitamin D insufficiency is associated with an increased risk of early clinical failure in follicular lymphoma
- Creators
- S. I. Tracy - Mayo ClinicM. J. Maurer - Mayo ClinicT. E. Witzig - Mayo ClinicM. T. Drake - Mayo ClinicS. M. Ansell - Mayo ClinicG. S. Nowakowski - Mayo ClinicC. A. Thompson - Mayo ClinicD. J. Inwards - Mayo ClinicP. B. Johnston - Mayo ClinicI. N. Micallef - Mayo ClinicC. Allmer - Mayo ClinicW. R. Macon - Mayo ClinicG. J. Weiner - University of IowaS. L. Slager - Mayo ClinicT. M. Habermann - Mayo ClinicB. K. Link - University of IowaJ. R. Cerhan - Division of Epidemiology/ Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA
- Resource Type
- Journal article
- Publication Details
- Blood cancer journal (New York), Vol.7(8), pp.e595-e595
- DOI
- 10.1038/bcj.2017.70
- PMID
- 28841207
- PMCID
- PMC5596381
- NLM abbreviation
- Blood Cancer J
- ISSN
- 2044-5385
- eISSN
- 2044-5385
- Publisher
- Springer Nature
- Number of pages
- 7
- Grant note
- P50CA097274 / NATIONAL CANCER INSTITUTE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI) P50 CA97274 / National Institutes of Health; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA Henry J. Predolin Foundation
- Language
- English
- Date published
- 08/25/2017
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Epidemiology; Pharmaceutical Sciences and Experimental Therapeutics; Internal Medicine
- Record Identifier
- 9984359768102771
Metrics
17 Record Views